By inhibiting this pathway, MSCs suppress TGF-β1-induced fibroblast activation, which is a central mechanism driving the excessive collagen deposition and scarring in IPF [21]. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.